Medtronic’s Implantable System for Remodulin to Treat Patients with Pulmonary Arterial Hypertension Gets FDA Approval

Medtronic implantable system for remodulin
Medtronic has received FDA approval for its Implantable System for Remodulin (ISR) as a new treatment option for people with pulmonary arterial hypertension (PAH). The system consists of Medtronic’s Synchromed II implantable drug infusion pump, an intravascular catheter, and United Therapeutics‘ Remodulin (treprostinil) Injection medication. United Therapeutics will lead the commercial promotion of the ISR, […]